The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro

Blood Transfusion

Volumn 11, Issue 4, 2013, Pages 510-517

  Schlimp, Christoph Johannes ^a   Cadamuro, Janne ^b   Solomon, Cristina ^a   Redl, Heinz ^a   Schöchl, Herbert ^a,c  

^a LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Trauma Hospital Salzburg   (Austria)

Author keywords

Dilutional coagulopathy; Factor XIII; Fibrinogen; Thromboelastometry

Indexed keywords

ALBUMIN; BLOOD CLOTTING FACTOR 13; DILUENT; FIBRINOGEN; FIBRINOGEN CONCENTRATE; GELATIN; HETASTARCH; SODIUM CHLORIDE;

ADULT; ARTICLE; ASSAY; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD SAMPLING; CLINICAL ARTICLE; COLLOID; DILUTION; FEMALE; FUNCTIONAL FIBRIN POLYMERISATION TEST; HEMATOLOGICAL PROCEDURE; HUMAN; IN VITRO STUDY; MALE; NORMAL HUMAN; NORMAL VALUE; POLYMERIZATION; REFERENCE VALUE; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY; THROMBOELASTOMETRY;

ADULT; DISSEMINATED INTRAVASCULAR COAGULATION; FACTOR XIII; FIBRINOGEN; GELATIN; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; MALE; MIDDLE AGED; PLASMA SUBSTITUTES; SERUM ALBUMIN; SODIUM CHLORIDE; THROMBELASTOGRAPHY;

EID: 84891952268     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2012.0171-12     Document Type: Article

References (44)

1. Liumbruno GM, Bennardello F, Lattanzio A, et al. Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period. Blood Transfus 2011; 9: 189-217.
2. Roberts I, Evans P, Bunn F, et al. Is the normalisation of blood pressure in bleeding trauma patients harmful? Lancet 2001; 357: 385-7.
3. Niemi TT, Kuitunen AH. Hydroxyethyl starch impairs in vitro coagulation. Acta Anaesthesiol Scand 1998; 42: 1104-9.
4. Hartog CS, Reuter D, Loesche W, et al. Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review. Intensive Care Med 2011; 37: 1725-37.
5. Choi PT, Yip G, Quinonez LG, Cook DJ. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999; 27: 200-10.
6. Franchini M, Lippi G. Fibrinogen replacement therapy: a critical review of the literature. Blood Transfus 2012; 10: 23-7.
7. Fenger-Eriksen C, Jensen TM, Kristensen BS, et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost 2009; 7: 795-802.
8. Schöchl H, Nienaber U, Maegele M, et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15: R83.
9. Warmuth M, Mad P, Wild C. Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults. Acta Anaesthesiol Scand 2012; 56: 539-48.
10. Schöchl H, Nienaber U, Hofer G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14: R55.
11. Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth 2010; 105: 116-21.
12. Levy JH, Szlam F, Tanaka KA, Sniecienski RM. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg 2012; 114: 261-74.
13. Gerlach R, Tolle F, Raabe A, et al. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased Factor XIII activity: implications of a prospective study. Stroke 2002; 33: 1618-23.
14. Nielsen VG. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiol Scand 2005; 49: 1163-71.
15. Korte W. F. XIII in perioperative coagulation management. Best Pract Res Clin Anaesthesiol 2010; 24: 85-93.
16. Lawrie AS, Green L, Mackie IJ, et al. Factor XIII - an under diagnosed deficiency - are we using the right assays? J Thromb Haemost 2010; 8: 2478-82.
17. Liumbruno GM. Thromboelastography and thromboelastometry and the management of intra-operative transfusion therapy in massively bleeding patients. Blood Transfus 2012; 10: 400-1.
18. Schöchl H, Cotton B, Inaba K, et al. FIBTEM provides early prediction of massive transfusion in trauma. Crit Care 2011; 15: R265.
19. Schöchl H, Solomon C, Traintinger S, et al. Thromboelastometric (ROTEM) findings in patients suffering from isolated severe traumatic brain injury. J Neurotrauma 2011; 28: 2033-41.
20. Lindroos AC, Schramko AA, Niiya T, et al. Effects of combined balanced colloid and crystalloid on rotational thromboelastometry in vitro. Perfusion 2011; 26: 422-7.
21. Haas T, Preinreich A, Oswald E, et al. Effects of albumin 5% and artificial colloids on clot formation in small infants. Anaesthesia 2007; 62: 1000-7.
22. Mittermayr M, Streif W, Haas T, et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 2007; 105: 905-17.
23. Schöchl H, Maegele M, Solomon C, et al. Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med 2012; 20: 15.
24. Nielsen VG, Gurley WQ Jr, Burch TM. The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography. Anesth Analg 2004; 99: 120-3.
25. Theusinger OM, Baulig W, Asmis LM, et al. In vitro factor XIII supplementation increases clot firmness in rotation thromboelastometry (ROTEM). Thromb Haemost 2010; 104: 385-91.
26. De Lorenzo C, Calatzis A, Welsch U, et al. Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%. Anesth Analg 2006; 102: 1194-200.
27. Haas T, Fries D, Velik-Salcher C. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution. Anesth Analg 2008; 106: 1360-5.
28. Rossaint R, Bouillon B, Cerny V, et al. Management of bleeding following major trauma: an updated European guideline. Crit Care 2010; 14: R52.
29. Weiss G, Lison S, Spannagl M, Heindl B. Expressiveness of global coagulation parameters in dilutional coagulopathy. Br J Anaesth 2010; 105: 429-36.
30. Hiippala ST. Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagul Fibrinolysis 1995; 6: 743-6.
31. Egli GA, Zollinger A, Seifert B, et al. Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. Br J Anaesth 1997; 78: 684-9.
32. Schramko AA, Kuitunen AH, Suojaranta-Ylinen RT, Niemi TT. Role of fibrinogen-, factor VIII- and XIII-mediated clot propagation in gelatin haemodilution. Acta Anaesthesiol Scand 2009; 53: 731-5.
33. Niemi TT, Kuitunen AH. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiol Scand 2005; 49: 373-8.
34. Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI, Kuitunen AH. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg 2006; 102: 998-1006.
35. Navickis RJ, Haynes GR, Wilkes MM. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: A metaanalysis of randomized trials. J Thorac Cardiovasc Surg 2012; 144: 223-30
36. Fries D, Innerhofer P, Reif C, et al. The effect of fibrinogen substitution on reversal of dilutional coagulopathy: an in vitro model. Anesth Analg 2006; 102: 347-51.
37. Dirkmann D, Görlinger K, Gisbertz C, et al. Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood. Anesth Analg 2012; 114: 1182-8.
38. Fries D, Streif W, Margreiter J, et al. The effects of perioperatively administered crystalloids and colloids on concentrations of molecular markers of activated coagulation and fibrinolysis. Blood Coagul Fibrinolysis 2004; 15: 213-9.
39. Haas T, Korte W, Spielmann N, et al. Perioperative course of FXIII in children undergoing major surgery. Paediatr Anaesth 2012; 22: 641-6.
40. Weber CF, Sanders JO, Friedrich K, et al. [Role of thrombelastometry for the monitoring of factor XIII. A prospective observational study in neurosurgical patients]. Hamostaseologie 2011; 31: 111-7.
41. Zambruni A, Thalheimer U, Leandro G, et al. Thromboelastography with citrated blood: comparability with native blood, stability of citrate storage and effect of repeated sampling. Blood Coagul Fibrinolysis 2004; 15: 103-7.
42. Jansen JO, Luke D, Davies E, et al. Temporal changes in ROTEM(®)-measured coagulability of citrated blood samples from coagulopathic trauma patients. Injury 2011 DOI 10.1016/j.injury.2011.12.003.
43. Drummond JC, Petrovitch CT. Intraoperative blood salvage: fluid replacement calculations. Anesth Analg 2005; 100: 645-9.
44. McIlroy DR, Kharasch ED. Acute intravascular volume expansion with rapidly administered crystalloid or colloid in the setting of moderate hypovolemia. Anesth Analg 2003; 96: 1572-7.